| Increasing vaccine potency through exosome antigen targeting ZC Hartman, J Wei, OK Glass, H Guo, G Lei, XY Yang, T Osada, ... Vaccine 29 (50), 9361-9367, 2011 | 220 | 2011 |
| HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis ZC Hartman, XY Yang, O Glass, G Lei, T Osada, SS Dave, MA Morse, ... Cancer research 71 (13), 4380-4391, 2011 | 155 | 2011 |
| Efficacy and safety of massage for osteoarthritis of the knee: a randomized clinical trial A Perlman, SG Fogerite, O Glass, E Bechard, A Ali, VY Njike, C Pieper, ... Journal of general internal medicine 34, 379-386, 2019 | 85 | 2019 |
| Expressive writing to improve resilience to trauma: A clinical feasibility trial O Glass, M Dreusicke, J Evans, E Bechard, RQ Wolever Complementary therapies in clinical practice 34, 240-246, 2019 | 85 | 2019 |
| Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum O Glass, C Filozof, M Noureddin, M Berner-Hansen, E Schabel, ... Journal of Hepatology 73 (3), 680-693, 2020 | 72 | 2020 |
| Serum interleukin‐8, osteopontin, and monocyte chemoattractant protein 1 are associated with hepatic fibrosis in patients with nonalcoholic fatty liver disease O Glass, R Henao, K Patel, CD Guy, HJ Gruss, WK Syn, CA Moylan, ... Hepatology communications 2 (11), 1344-1355, 2018 | 71 | 2018 |
| Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity T Osada, XY Yang, ZC Hartman, O Glass, BL Hodges, D Niedzwiecki, ... Cancer gene therapy 16 (9), 673-682, 2009 | 68 | 2009 |
| Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity ZC Hartman, T Osada, O Glass, XY Yang, G Lei, HK Lyerly, TM Clay Cancer research 70 (18), 7209-7220, 2010 | 44 | 2010 |
| Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study OK Glass, BA Inman, G Broadwater, KS Courneya, JR Mackey, S Goruk, ... British journal of cancer 112 (5), 825-831, 2015 | 39 | 2015 |
| An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity ZC Hartman, J Wei, T Osada, O Glass, G Lei, XY Yang, S Peplinski, ... Clinical Cancer Research 16 (5), 1466-1477, 2010 | 35 | 2010 |
| Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the … ZC Hartman, DM Appledorn, D Serra, O Glass, TB Mendelson, TM Clay, ... Virology 374 (2), 453-467, 2008 | 35 | 2008 |
| Differential response to exercise in claudin-low breast cancer OK Glass, M Bowie, J Fuller, D Darr, J Usary, K Boss, KR Choudhury, ... Oncotarget 8 (60), 100989, 2017 | 25 | 2017 |
| Feasibility, acceptability, and potential effectiveness of an online expressive writing intervention for COVID-19 resilience E Bechard, J Evans, E Cho, Y Lin, A Kozhumam, J Jones, S Grob, O Glass Complementary therapies in clinical practice 45, 101460, 2021 | 22 | 2021 |
| Exercise training as treatment of nonalcoholic fatty liver disease OK Glass, A Radia, WE Kraus, MF Abdelmalek Journal of Functional Morphology and Kinesiology 2 (4), 35, 2017 | 20 | 2017 |
| Perceptions of exercise and its challenges in patients with nonalcoholic fatty liver disease: a survey‐based study O Glass, D Liu, E Bechard, CD Guy, J Pendergast, A Mae Diehl, ... Hepatology Communications 6 (2), 334-344, 2022 | 15 | 2022 |
| Resistance exercise training in patients with genitourinary cancers to mitigate treatment-related skeletal muscle loss OK Glass, S Ramalingam, MR Harrison Clin Adv Hematol Oncol 14 (6), 436-46, 2016 | 6 | 2016 |
| A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) L Gentile, T Coelho, A Dispenzieri, I Conceição, M Waddington-Cruz, ... Orphanet journal of rare diseases 18 (1), 350, 2023 | 4 | 2023 |
| Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey J González-Moreno, A Dispenzieri, M Grogan, T Coelho, I Tournev, ... Cardiology and Therapy 13 (1), 117-135, 2024 | 1 | 2024 |
| Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay T Coelho, A Dispenzieri, M Grogan, I Conceição, M Waddington-Cruz, ... Amyloid 30 (4), 445-448, 2023 | 1 | 2023 |
| Acupuncture for acute musculoskeletal pain management in the emergency department and continuity clinic: a protocol for an adaptive pragmatic randomised controlled trial SA Eucker, O Glass, CA Staton, MR Knisely, A O’Regan, C De Larco, ... BMJ open 12 (9), e061661, 2022 | 1 | 2022 |
